In the News Christine Mackenzie 3/1/26 In the News Christine Mackenzie 3/1/26

Scaling CRISPR For Rare Disease With Aurora Therapeutics' Dr. Edward Kaye

Cell & Gene

Read More

In the News Christine Mackenzie 2/17/26 In the News Christine Mackenzie 2/17/26

Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.

Forbes

Read More

In the News Christine Mackenzie 2/12/26 In the News Christine Mackenzie 2/12/26

Biotech CEOs discuss the state of the industry, what is needed to compete globally, the importance of having a patient-centric approach, and more

Biotech TV

Read More

In the News Christine Mackenzie 1/21/26 In the News Christine Mackenzie 1/21/26

JPM 2026: Aurora Therapeutics’ Edward Kaye on Scalable Personalized Gene Editing

Inside Precision Medicine

Read More

In the News Christine Mackenzie 1/9/26 In the News Christine Mackenzie 1/9/26

Aurora sets out to capitalize on FDA’s new framework for bespoke drug therapies

BioPharma Dive

Read More

In the News Christine Mackenzie 1/9/26 In the News Christine Mackenzie 1/9/26

Key scientist from Baby KJ team launches startup to scale personalized CRISPR medicines

STAT

Read More

Press Release Jamison Wright 1/9/26 Press Release Jamison Wright 1/9/26

Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases

Read More

In the News Jamison Wright 1/9/26 In the News Jamison Wright 1/9/26

Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments

Wired

Read More

In the News Jamison Wright 1/9/26 In the News Jamison Wright 1/9/26

Gene editing pioneers launch first startup focused on custom CRISPR therapies

Endpoints News

Read More